AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17105841 — intervention group
Group type: COMPARATOR
Intervention: OCP alone
Number of subjects: 48
Study 16232016 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat emulsion administered through the ECMO circuit (1-3 g/kg/day)
Number of subjects: 9
Study 16232016 — intervention group
Group type: COMPARATOR
Intervention: Fat emulsion administered through separate intravenous access (1-3 g/kg/day)
Number of subjects: 9
Study 12070007 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus prednisone
Number of subjects: 287
Study 12070007 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 287
Study 9810316 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course preoperative radiation therapy
Number of subjects: 1168
Study 9810316 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radiotherapy with conventional doses and concurrent fluorouracil-based chemotherapy
Number of subjects: 1168
Study 9810316 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy
Number of subjects: 1168
Study 9810316 — intervention group
Group type: COMPARATOR
Intervention: Postoperative combination therapy
Number of subjects: 1168
Study 11362207 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-538 (300 mg, 400 mg, 500 mg, or 600 mg, administered twice daily)
Number of subjects: 0
Study 11362207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2624830 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivicaine (Marcain) ilioinguinal nerve block
Number of subjects: 60
Study 2624830 — intervention group
Group type: COMPARATOR
Intervention: No bupivicaine (Control Group B)
Number of subjects: 60
Study 979871 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (bicycle ergometer training for 15 minutes, 3 times weekly at 140 bpm)
Number of subjects: 40
Study 979871 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 40
Study 979871 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 30986535 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 237
Study 30986535 — intervention group
Group type: COMPARATOR
Intervention: Oral naltrexone (O-NTX)
Number of subjects: 237
Study 28818854 — intervention group
Group type: EXPERIMENTAL
Intervention: nMDZ (midazolam)
Number of subjects: 60
Study 28818854 — intervention group
Group type: COMPARATOR
Intervention: nKTM (ketamine)
Number of subjects: 60
Study 28818854 — intervention group
Group type: EXPERIMENTAL
Intervention: nMDZ (midazolam) and nKTM (ketamine)
Number of subjects: 60
Study 26940112 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery-focused Cognitive Behavioural Therapy for Older Adults (RfCBT-OA) plus treatment as usual (TAU)
Number of subjects: 50
Study 26940112 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 50
Study 24698798 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimally-medicated (ON meds) during split-belt treadmill (SBT) walking
Number of subjects: 10
Study 24698798 — intervention group
Group type: COMPARATOR
Intervention: Withholding dopaminergic medication (OFF meds) during split-belt treadmill (SBT) walking
Number of subjects: 10
Study 22369555 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (treatment group, n = 22)
Number of subjects: 40
Study 22369555 — intervention group
Group type: COMPARATOR
Intervention: No periodontal treatment (control group, n = 18)
Number of subjects: 40
Study 20869984 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance-tailored therapy (MTT)
Number of subjects: 213
Study 20869984 — intervention group
Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT)
Number of subjects: 213
Study 17942759 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin
Number of subjects: 10001
Study 17942759 — intervention group
Group type: COMPARATOR
Intervention: 10 mg atorvastatin
Number of subjects: 10001
Study 15827447 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg or 10 mg) once daily for up to 5 years
Number of subjects: 243
Study 15827447 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg) once daily for up to 5 years
Number of subjects: 243
Study 15827447 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 243
Study 12789464 — intervention group
Group type: EXPERIMENTAL
Intervention: RC + CT + A (radiochemotherapy plus amifostine)
Number of subjects: 56
Study 12789464 — intervention group
Group type: COMPARATOR
Intervention: RC + CT (radiochemotherapy alone)
Number of subjects: 56
Study 10364989 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin
Number of subjects: 42
Study 10364989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight hydroxyethyl starch (HES)
Number of subjects: 42
Study 10364989 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 42
Study 8913472 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% erythromycin
Number of subjects: 225
Study 8913472 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 225
Study 1882922 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 20
Study 1882922 — intervention group
Group type: COMPARATOR
Intervention: Argon laser
Number of subjects: 20
Study 6760123 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibekacin
Number of subjects: 30
Study 6760123 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 30
Study 30900426 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT) with Fagales pollen extracts
Number of subjects: 56
Study 30900426 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 56
Study 29645365 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural ultrasound (US)
Number of subjects: 80
Study 29645365 — intervention group
Group type: COMPARATOR
Intervention: Palpation method
Number of subjects: 80
Study 26849094 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath® Series 5 videolaryngoscope
Number of subjects: 49
Study 26849094 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 49
Study 24213960 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training
Number of subjects: 22
Study 24213960 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision Training
Number of subjects: 22
Study 24213960 — intervention group
Group type: COMPARATOR
Intervention: Both types of training
Number of subjects: 22
Study 23173418 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU treatment at 3.5 W in group A
Number of subjects: 80
Study 23173418 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU treatment at 4.0 W in group B
Number of subjects: 80
Study 23173418 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU treatment at 4.5 W in group C
Number of subjects: 80
Study 23173418 — intervention group
Group type: COMPARATOR
Intervention: Control group D (no treatment)
Number of subjects: 80
Study 21155091 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 286
Study 21155091 — intervention group
Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 286
Study 17414813 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise withdrawal (N=20)
Number of subjects: 40
Study 17414813 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued regular aerobic exercise, N=20)
Number of subjects: 40
Study 15786480 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) combined with photodynamic therapy (PDT) using systemic 5-aminolaevulinic acid (5-ALA) as the photosensitiser
Number of subjects: 0
Study 15786480 — intervention group
Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL) alone
Number of subjects: 0
Study 12366728 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 200 mg
Number of subjects: 20
Study 12366728 — intervention group
Group type: COMPARATOR
Intervention: Topiramate 50 mg
Number of subjects: 20
Study 12366728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9396404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine therapy
Number of subjects: 489
Study 9396404 — intervention group
Group type: COMPARATOR
Intervention: Evaluation committee (EC) review
Number of subjects: 489
Study 8197239 — intervention group
Group type: EXPERIMENTAL
Intervention: Roland‐Morris (RM) questionnaire
Number of subjects: 88
Study 8197239 — intervention group
Group type: EXPERIMENTAL
Intervention: Oswestry (OSW) questionnaire
Number of subjects: 88
Study 8197239 — intervention group
Group type: EXPERIMENTAL
Intervention: Jan van Breemen Institute (JVB) pain questionnaire
Number of subjects: 88
Study 8197239 — intervention group
Group type: COMPARATOR
Intervention: Jan van Breemen Institute (JVB) function questionnaire
Number of subjects: 88
Study 2454362 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (50 mg)
Number of subjects: 16
Study 2454362 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 16
Study 30721231 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroFIT intervention (12-week, group-based programme delivered in 12 weekly 90-minute sessions)
Number of subjects: 1113
Study 30721231 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroFIT intervention
Number of subjects: 1113
Study 30721231 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (12-month waiting list)
Number of subjects: 1113
Study 29076760 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 12
Study 29076760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23681925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural guided self-help plus psychopharmacotherapy
Number of subjects: 90
Study 23681925 — intervention group
Group type: COMPARATOR
Intervention: Psychopharmacotherapy alone
Number of subjects: 90
Study 22269589 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-affect/self-affirmation (PA) intervention group
Number of subjects: 242
Study 22269589 — intervention group
Group type: COMPARATOR
Intervention: Patient education (PE) control group
Number of subjects: 242
Study 19404806 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg ropivacaine, 30 mg ketorolac, and 0.5 mg epinephrine (total volume 106 mL) infiltrated intraoperatively
Number of subjects: 40
Study 19404806 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg ropivacaine, 30 mg ketorolac, and 0.1 mg epinephrine injected intraarticularly via a catheter 21 hours postoperatively
Number of subjects: 40
Study 17984806 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mug Vi polysaccharide vaccine (revaccination)
Number of subjects: 998
Study 17984806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 998
Study 17984806 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi polysaccharide vaccine (primary vaccination)
Number of subjects: 998
Study 15522941 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol (E2)
Number of subjects: 40
Study 15522941 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (E2)
Number of subjects: 40
Study 15522941 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral medroxyprogesterone acetate (MPA)
Number of subjects: 40
Study 15522941 — intervention group
Group type: COMPARATOR
Intervention: Baseline levels of CRP
Number of subjects: 40
Study 11589260 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0
Study 11589260 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 0
Study 9884851 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.2 mg mL‐1 plus lignocaine 3.2 mg mL‐1 (group ML)
Number of subjects: 50
Study 9884851 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.2 mg mL‐1 (group M)
Number of subjects: 50
Study 8052119 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental exercise (INC)
Number of subjects: 9
Study 8052119 — intervention group
Group type: COMPARATOR
Intervention: Constant load exercise (CL)
Number of subjects: 9
Study 2856056 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine + Fenfluramine
Number of subjects: 6
Study 2856056 — intervention group
Group type: COMPARATOR
Intervention: Fenfluramine alone
Number of subjects: 6
Study 2856056 — intervention group
Group type: COMPARATOR
Intervention: Clonidine alone
Number of subjects: 6
Study 2856056 — intervention group
Group type: COMPARATOR
Intervention: Placebo Clonidine
Number of subjects: 6
Study 8157728 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate/Etidronate
Number of subjects: 68
Study 8157728 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo/Etidronate
Number of subjects: 68
Study 8157728 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Placebo
Number of subjects: 68
Study 8157728 — intervention group
Group type: COMPARATOR
Intervention: Phosphate/Placebo
Number of subjects: 68
Study 377521 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (Imodium; (Janssen) Ethnor)
Number of subjects: 0
Study 377521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31813739 — intervention group
Group type: EXPERIMENTAL
Intervention: IC‐ISBT (image-based combined intracavitary-interstitial brachytherapy)
Number of subjects: 94
Study 30723912 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 198
Study 30723912 — intervention group
Group type: COMPARATOR
Intervention: Vaginal dinoprostone insert
Number of subjects: 198
Study 30723912 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 198
Study 28835029 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgingival glycine air polishing
Number of subjects: 22
Study 28835029 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaling combined with 0.12% chlorhexidine rinsing
Number of subjects: 22
Study 25828348 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg losartan daily
Number of subjects: 3834
Study 25828348 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg losartan daily
Number of subjects: 3834
Study 25828348 — intervention group
Group type: COMPARATOR
Intervention: High dose losartan
Number of subjects: 3834
Study 23955995 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 160
Study 23955995 — intervention group
Group type: COMPARATOR
Intervention: Glipizide GITS
Number of subjects: 160
Study 23955995 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (lean subgroup, BMI < 25 kg/m(2))
Number of subjects: 160
Study 21422418 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline (epirubicin) monotherapy
Number of subjects: 149
Study 21422418 — intervention group
Group type: EXPERIMENTAL
Intervention: TOP2A amplification
Number of subjects: 149
Study 21422418 — intervention group
Group type: EXPERIMENTAL
Intervention: A-Score combining TOP2A gene signature and two other signatures
Number of subjects: 149
Study 19410976 — intervention group
Group type: EXPERIMENTAL
Intervention: (1,3)(1,6)-beta-D-glycan (BDG) 3 x 0.5 g daily for 4 weeks
Number of subjects: 12
Study 19410976 — intervention group
Group type: COMPARATOR
Intervention: Placebo (waxy maize starch) 3 x 0.5 g daily for 4 weeks
Number of subjects: 12
Study 17912137 — intervention group
Group type: EXPERIMENTAL
Intervention: Various stroke rehabilitation interventions (specific interventions not detailed)
Number of subjects: 491
Study 17912137 — intervention group
Group type: EXPERIMENTAL
Intervention: Previously published assessment tools
Number of subjects: 491
Study 17912137 — intervention group
Group type: EXPERIMENTAL
Intervention: Study specific assessment tools
Number of subjects: 491
Study 17912137 — intervention group
Group type: EXPERIMENTAL
Intervention: Core of frequently cited tools
Number of subjects: 491
Study 16043724 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 87
Study 16043724 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 87
Study 11527891 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG (150 IU) after day 8 of stimulation
Number of subjects: 43
Study 11527891 — intervention group
Group type: EXPERIMENTAL
Intervention: rFSH (375 IU) after day 8 of stimulation
Number of subjects: 43
Study 11527891 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 BMI and age matched patients with optimal ovarian response)
Number of subjects: 43
Study 9272895 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation by nurses during pregnancy and infancy
Number of subjects: 324
Study 9272895 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation by nurses
Number of subjects: 324
Study 8197931 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy after hormonal treatment (560 mg of estramustine phosphate daily for 6 weeks)
Number of subjects: 127
Study 8197931 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy alone
Number of subjects: 127
Study 3110382 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 96
Study 3110382 — intervention group
Group type: COMPARATOR
Intervention: Enteral Nutrition (EN)
Number of subjects: 96
Study 31011944 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) - brief (15 min) mindfulness body-scan audio
Number of subjects: 220
Study 31011944 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 220
Study 29093779 — intervention group
Group type: EXPERIMENTAL
Intervention: Autografts
Number of subjects: 35
Study 29093779 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HA and DBM
Number of subjects: 35
Study 26682289 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle foaming HMP-containing facial cleanser with fragrance
Number of subjects: 161
Study 26682289 — intervention group
Group type: COMPARATOR
Intervention: Benchmark gentle, fragrance-free, nonfoaming cleanser
Number of subjects: 161
Study 23784924 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 16 mg/kg/day (≤1000 mg) for 3 days
Number of subjects: 66
Study 23784924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 20947156 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-step and 2-step etch-and-rinse systems
Number of subjects: 36
Study 20947156 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-step/3-step self-etching systems
Number of subjects: 36
Study 20947156 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged water storage of specimens
Number of subjects: 36
Study 20947156 — intervention group
Group type: EXPERIMENTAL
Intervention: μTBS values after 8 h and 6 months of storage
Number of subjects: 36
Study 20947156 — intervention group
Group type: EXPERIMENTAL
Intervention: μTBS values
Number of subjects: 36
Study 19638088 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS plus ERC in a single session
Number of subjects: 80
Study 19638088 — intervention group
Group type: COMPARATOR
Intervention: EUS plus ERC in two separate sessions
Number of subjects: 80
Study 17148536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored CD-ROM educational intervention
Number of subjects: 0
Study 17148536 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 12953307 — intervention group
Group type: EXPERIMENTAL
Intervention: CDDP/epi gel
Number of subjects: 87
Study 12953307 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 87
Study 10081698 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal treatment (NHT) for three months
Number of subjects: 139
Study 10081698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative therapy)
Number of subjects: 139
Study 7730488 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication of H pylori
Number of subjects: 66
Study 1838772 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple therapy (n = 33), consisting of five monthly sessions attended by two family therapists.
Number of subjects: 63
Study 1838772 — intervention group
Group type: COMPARATOR
Intervention: Control group without couple therapy (n = 30).
Number of subjects: 63
Study 7275460 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet consisting entirely of protein
Number of subjects: 0
Study 7275460 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet consisting of protein plus carbohydrate
Number of subjects: 0
Study 31873952 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (12 weeks of combined resistance and aerobic exercise)
Number of subjects: 35
Study 31873952 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 30345673 — intervention group
Group type: EXPERIMENTAL
Intervention: Holograms
Number of subjects: 179
Study 30345673 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐DPDFs
Number of subjects: 179
Study 30345673 — intervention group
Group type: COMPARATOR
Intervention: Printed images
Number of subjects: 179
Study 27618248 — intervention group
Group type: EXPERIMENTAL
Intervention: ApPA-AvSB condition
Number of subjects: 115
Study 27618248 — intervention group
Group type: EXPERIMENTAL
Intervention: ApSB-AvPA condition
Number of subjects: 115
Study 27618248 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 115
Study 24622016 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 0.5 mg/1 ml
Number of subjects: 90
Study 24622016 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 2 mg/1 ml
Number of subjects: 90
Study 24622016 — intervention group
Group type: COMPARATOR
Intervention: Sodium Chloride (NS) 0.9% solution (1 ml)
Number of subjects: 90
Study 23278583 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended transsternal thymectomy
Number of subjects: 0
Study 23278583 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 20528293 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure (VRE) therapy
Number of subjects: 11
Study 20528293 — intervention group
Group type: COMPARATOR
Intervention: Present‐centered therapy (PCT)
Number of subjects: 11
Study 18808630 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group (listened to selected sedative music using headphones)
Number of subjects: 44